GL1X · GenesisL1 explorer

MolNFT v1 · #17488 · protein

T4 lysozyme cavity mutant L99A/M102Q bound with 2-allylphenol

1OV5: “T4 lysozyme cavity mutant L99A/M102Q bound with 2-allylphenol”. X-ray diffraction, 2 ligands (2LP, CL), 2 pockets (best druggability 0.72). MolNFT v1 #17488 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
1OV5
Type
protein
Length
162 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Lysozyme
EC
3.2.1.17
UniProt
P00720
Ligands
2LP, CL
Pockets
2 · best druggability 0.72

Structure

x-ray diffraction · 1 distinct chain · 65% helix, 9% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ALysozyme (EC 3.2.1.17)protein16265% helix, 9% strandP00720

Ligands and binding sites

  • 2LP · 2-allylphenol · ligand · chains A
  • CL · Chloride ion · ion · 2 copies · chains A
  • BME · Beta-mercaptoethanol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1520.720.98152LP
22990.540.7533empty

Compared structures

  • 1OV5 · T4 Lysozyme Cavity Mutant L99a/M102Q Bound With 2-Allylphenol · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.